Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00491894Phase 3Completed
Phase 3, open-label, single-arm trial of glycopyrronium in sialorrhea, sponsored by Shionogi & Co., Ltd. Primary endpoint: Proportion of Responders According to the Modified Teacher's Drooling Scale at 6 months. Started Mar 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00491894.